共 59 条
The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links
被引:73
作者:
Al-Minawi, Ali Z.
[1
,2
]
Lee, Yin-Fai
[3
]
Hakansson, Daniel
[1
]
Johansson, Fredrik
[1
]
Lundin, Cecilia
[3
]
Saleh-Gohari, Nasrollah
[4
]
Schultz, Niklas
[1
]
Jenssen, Dag
[1
]
Bryant, Helen E.
[2
]
Meuth, Mark
[2
]
Hinz, John M.
[5
]
Helleday, Thomas
[1
,3
]
机构:
[1] Stockholm Univ, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden
[2] Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England
[3] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England
[4] Kerman Univ Med Sci, Sch Med, Dept Genet, Bozorgrah Emam 7616914111, Kerman, Iran
[5] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA
基金:
英国医学研究理事会;
瑞典研究理事会;
关键词:
NUCLEOTIDE-EXCISION-REPAIR;
CHINESE-HAMSTER CELLS;
PIGMENTOSUM GROUP-F;
MAMMALIAN-CELLS;
MITOMYCIN-C;
BREAK REPAIR;
IN-VIVO;
S-PHASE;
ERCC1-XPF;
SENSITIVITY;
D O I:
10.1093/nar/gkp705
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Both the ERCC1-XPF complex and the proteins involved in homoIogous recombination (HR) have critical roles in inter-strand cross-link (ICL) repair. Here, we report that mitomycin C-induced lesions inhibit replication fork elongation. Furthermore, mitomycin C-induced DNA double-strand breaks (DSBs) are the result of the collapse of ICL-stalled replication forks. These are not formed through replication run off, as we show that mitomycin C or cisplatin-induced DNA lesions are not incised by global genome nucleotide excision repair (GGR). We also suggest that ICL-lesion repair is initiated either by replication or transcription, as the GGR does not incise ICL-lesions. Furthermore, we report that RAD51 foci are induced by cisplatin or mitomycin C independently of ERCC1, but that mitomycin C-induced HR measured in a reporter construct is impaired in ERCC1-defective cells. These data suggest that ERCC1-XPF plays a role in completion of HR in ICL repair. We also find no additional sensitivity to cisplatin by siRNA co-depletion of XRCC3 and ERCC1, showing that the two proteins act on the same pathway to promote survival.
引用
收藏
页码:6400 / 6413
页数:14
相关论文